MedTrace Logo

Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis

NCT04672889 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-01-10

No results posted yet for this study

Summary

In order to understand the life history of the breast milk flora, explore its composition, source of strains, and ability to colonize the baby's intestinal environment, to find out strains with the potential of probiotics in breast milk

Conditions

  • Intestinal Bacteria Flora Disturbance

Interventions

DIETARY_SUPPLEMENT

Placebo

consume 1 sachet per day for 1 months

DIETARY_SUPPLEMENT

Babyguard® Breast Milk Probiotics

consume 1 sachet per day for 1 months

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Ming Shiang Wu, Doctor · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-09-30
Completion
2024-11-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04672889 on ClinicalTrials.gov